Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 10 pages · Chinese
Release
Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Earlier from Vcanbio Cell & Gene Engineering
- Announcement on 2025 Annual Profit Distribution Plan
- Announcement on Progress in Wholly-owned Subsidiary’s Clinical Trial for VUM02 Injection
- Announcement on Progress in Using Temporarily Idle Raised Funds for Cash Management
- Announcement on Redemption of Idle Raised Funds Used for Cash Management upon Maturity
- Announcement on Subsidiary’s Receipt of a Medical Device Registration Certificate
Later from Vcanbio Cell & Gene Engineering
- Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening the 2025 Annual Performance Briefing
- Announcement on Progress in Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
- Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering